PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 15 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

21 March 2026

  1. (diff | hist) 07:04 Blind sampling 8,193 ±0 Chromatokid (talk | contribs) clarify that a signature on a certificate is a release, not a verification [rollback]
  2. (diff | hist) 05:19 International nonproprietary name 4,356 ±0 NauseaNoor (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]

20 March 2026

  1. (diff | hist) m b 23:56 Crude peptide 4,775 ±0 CiteBot (talk | contribs) bot: normalise temperature formatting [rollback]
  2. (diff | hist) m 22:27 Research use only 7,990 ±0 SafetySignalSid (talk | contribs) add the pharmacopoeial chapter reference [rollback]
  3. (diff | hist) m b 20:58 Karl Fischer titration 9,318 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) m 19:12 Haemoglobin A1c 4,243 ±0 EpitalonEoin (talk | contribs) convert the interval table to include both conventional and SI units [rollback]
  5. (diff | hist) 19:10 Cagrilintide 4,256 ±0 TriumphThad (talk | contribs) ce [rollback]
  6. (diff | hist) 16:14 HOMA-IR 4,511 ±0 BaselineBex (talk | contribs) add the seasonal variation point, sourced [rollback]
  7. (diff | hist) 13:05 Talk:Methionine oxidation 611 +97 Chromatokid (talk | contribs) /* Contrast with deamidation detectability */ reply
  8. (diff | hist) 09:33 Gastric emptying 5,565 ±0 GsCouplingGil (talk | contribs) expand §Normal physiology [rollback]
  9. (diff | hist) 09:30 Talk:Methionine oxidation 400 +135 MassSpecMarv (talk | contribs) /* Contrast with deamidation detectability */ new section
  10. (diff | hist) 09:07 Adverse effects of GLP-1 receptor agonists 5,791 ±0 AnaesthesiaAoife (talk | contribs) split the gastrointestinal effects from the metabolic ones [rollback]
  11. (diff | hist) m 06:32 Guangzhou JEEP Biotechnology 15,452 ±0 Peptide_Pete (talk | contribs) typo [rollback]

19 March 2026

  1. (diff | hist) 19:21 Peptide content 8,404 ±0 GradientGus (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) 15:00 Talk:Satiety signalling 748 +215 ArcuateArt (talk | contribs) /* Energy expenditure claim */ reply
  3. (diff | hist) 13:45 Talk:Active pharmaceutical ingredient 611 +165 LabelLibby (talk | contribs) /* Pharmaceutical grade is not a term */ reply
  4. (diff | hist) 13:40 Talk:Glucose-dependent insulinotropic polypeptide 748 +164 Peptide_Pete (talk | contribs) /* Adipose-tissue mechanism remains speculative */ reply
  5. (diff | hist) m 13:11 Bachem Holding (Suzhou) 15,124 ±0 ForgeryFinder (talk | contribs) state what the certificate supplied with orders carries [rollback]
  6. (diff | hist) m 11:47 Qingdao Saber Technology Pharmaceutical 14,372 ±0 GastroparesisGwen (talk | contribs) expand §Reception [rollback]
  7. (diff | hist) 11:30 Talk:Satiety signalling 537 +103 BalanceBirdie (talk | contribs) /* Energy expenditure claim */ new section
  8. (diff | hist) 11:08 Shanghai Sigma-Audley New Material Technology 15,579 ±0 VerifyFirstVida (talk | contribs) add short description [rollback]
  9. (diff | hist) 11:05 Talk:Glucose-dependent insulinotropic polypeptide 537 +244 AnalyticalAnnie (talk | contribs) /* Adipose-tissue mechanism remains speculative */ new section
  10. (diff | hist) 10:10 Talk:Active pharmaceutical ingredient 400 +174 API_Aurora (talk | contribs) /* Pharmaceutical grade is not a term */ new section
  11. (diff | hist) 08:20 Talk:Exenatide 822 +98 ExenatideEzra (talk | contribs) /* Class-effect caution */ reply
  12. (diff | hist) 03:56 Insulin syringe unit conversion 6,290 ±0 Hedgerow_Hal (talk | contribs) the calculator rounded before dividing; corrected [rollback]
  13. (diff | hist) m 02:00 Syringe dead space 20,859 +519 Hedgerow_Hal (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  14. (diff | hist) 01:58 Peptide supply chain 8,410 ±0 SupplyWatchSuri (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  15. (diff | hist) m 00:29 Loss on drying 4,874 ±0 ColdChainCleo (talk | contribs) add the cross-link to the compendial chapter [rollback]

18 March 2026

  1. (diff | hist) 13:16 Glossary of peptide terminology 4,744 ±0 PBM_Perrin (talk | contribs) correct an entry that duplicated the one above it [rollback]
  2. (diff | hist) 13:10 Talk:C-peptide 611 +91 eGFR_Esme (talk | contribs) /* Renal clearance caveat */ reply
  3. (diff | hist) 12:50 Talk:Exenatide 611 +184 SelectTrialSam (talk | contribs) /* Class-effect caution */ reply
  4. (diff | hist) 09:35 Talk:C-peptide 400 +130 CPeptidePaddy (talk | contribs) /* Renal clearance caveat */ new section
  5. (diff | hist) 09:35 Talk:Exenatide 400 +168 ExenatideEzra (talk | contribs) /* Class-effect caution */ new section
  6. (diff | hist) 01:50 Fasting insulin 4,198 ±0 ColdChainCleo (talk | contribs) add the biological variation figure with its citation [rollback]

17 March 2026

  1. (diff | hist) m 22:38 WuXi TIDES 16,434 ±0 TallySheetTad (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) 21:53 Tirzepatide 8,037 ±0 MazdutideMads (talk | contribs) add the molecular formula to the infobox [rollback]
  3. (diff | hist) 20:38 SURPASS trial programme 5,078 ±0 SortKeySascha (talk | contribs) add the randomisation ratio [rollback]
  4. (diff | hist) m 17:31 USP General Chapter 85 5,180 ±0 LipidLedgerLou (talk | contribs) add the detection wavelength [rollback]
  5. (diff | hist) 13:40 Talk:USP General Chapter 85 611 +147 EndotoxinEd (talk | contribs) /* Tested by versus meets the limit */ reply
  6. (diff | hist) 13:25 Talk:Drug master file 611 +60 Compounding_Cate (talk | contribs) /* A filing is not an approval */ reply
  7. (diff | hist) 10:05 Talk:USP General Chapter 85 400 +174 COA_Colwyn (talk | contribs) /* Tested by versus meets the limit */ new section
  8. (diff | hist) 09:50 Talk:Drug master file 400 +134 DMF_Dermot (talk | contribs) /* A filing is not an approval */ new section
  9. (diff | hist) m 08:54 SUSTAIN trial programme 5,153 ±0 NPOV_Nadia (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]
  10. (diff | hist) m b 06:10 Receptor bias 4,477 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  11. (diff | hist) m 05:39 Arcuate nucleus 5,251 ±0 IncretinIvo (talk | contribs) add the citation for the co-secretion finding [rollback]
  12. (diff | hist) 04:44 LEADER trial 4,799 ±0 EndpointEnid (talk | contribs) add the trial registration identifier [rollback]

16 March 2026

  1. (diff | hist) 23:19 Amino acid analysis 4,943 ±0 CouplingCillian (talk | contribs) add the reference standard and its traceability [rollback]
  2. (diff | hist) 20:20 Shenzhen Hybio Pharmaceutical 17,496 +1,144 COA_Colwyn (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  3. (diff | hist) 13:50 Talk:Batch number 611 +102 COA_Colwyn (talk | contribs) /* Date-ordering check */ reply
  4. (diff | hist) 13:20 Talk:FLOW trial 611 +94 PreregPriya (talk | contribs) /* Early stopping inflates estimates */ reply
  5. (diff | hist) 10:42 Orforglipron 5,647 ±0 DMF_Dermot (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  6. (diff | hist) 10:20 Talk:Batch number 400 +163 BatchNumberBede (talk | contribs) /* Date-ordering check */ new section
  7. (diff | hist) 09:45 Talk:FLOW trial 400 +175 FlowTrialFraser (talk | contribs) /* Early stopping inflates estimates */ new section
  8. (diff | hist) 09:04 Multi-dose vial 24,688 +519 PatientPanelPru (talk | contribs) add the beyond-use interval with the storage condition it assumes [rollback]
  9. (diff | hist) m 09:00 Analytical method validation 5,342 ±0 TFA_Counterion (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  10. (diff | hist) 08:52 Talk:Temperature excursion 1,655 +172 MergeMorwenna (talk | contribs) /* Should freezing be a separate article? */ reply
  11. (diff | hist) m 05:20 Beyond-use date 23,171 ±0 BUD_Bertram (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  12. (diff | hist) 03:15 AmbioPharm 15,850 +798 SatietySunniva (talk | contribs) fix hyphenation per PP:MOS [rollback]
  13. (diff | hist) m b 02:10 Solid-phase peptide synthesis 5,359 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]

15 March 2026

  1. (diff | hist) 17:55 Batch number 4,573 ±0 Peptide_Pete (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  2. (diff | hist) 16:05 Talk:Enteroendocrine L cell 748 +159 Hedgerow_Hal (talk | contribs) /* Microbiome mention feels speculative */ reply
  3. (diff | hist) m 15:44 PeptideMeter 4,925 ±0 ReportReaderRilla (talk | contribs) split §What a report shows from §What it does not [rollback]
  4. (diff | hist) 14:38 FLOW trial 4,583 ±0 UnitsUrsula (talk | contribs) add the confidence interval to the point estimate [rollback]
  5. (diff | hist) 11:40 Talk:Enteroendocrine L cell 537 +257 NPOV_Nadia (talk | contribs) /* Microbiome mention feels speculative */ new section
  6. (diff | hist) 07:02 C-peptide 4,400 ±0 eGFR_Esme (talk | contribs) attribute the population interval to the cohort it was derived from [rollback]

14 March 2026

  1. (diff | hist) 23:16 Chain of custody 5,157 ±0 GastroparesisGwen (talk | contribs) expand §What the record contains [rollback]
  2. (diff | hist) m 21:36 GL Biochem (Shanghai) 16,491 ±0 Chromatokid (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  3. (diff | hist) m 17:14 Xi'an Mokemei Biotechnology 15,421 ±0 EndpointEnid (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  4. (diff | hist) 15:05 Talk:Orforglipron 748 +157 CuriousCallum (talk | contribs) /* Species selectivity */ reply
  5. (diff | hist) 12:08 Shanghai ERP Biotechnology 14,417 ±0 SelectTrialSam (talk | contribs) state which lines are held in regional stock [rollback]
  6. (diff | hist) 11:45 Talk:Orforglipron 537 +175 ReceptorRhoda (talk | contribs) /* Species selectivity */ new section
  7. (diff | hist) 11:12 Cost per milligram 4,125 ±0 Retention_Time_Rae (talk | contribs) fix the anchor on an internal link [rollback]
  8. (diff | hist) 10:57 Hypoglycaemia 4,473 ±0 PancreasPru (talk | contribs) flag the section as needing a source for two remaining figures [rollback]
  9. (diff | hist) 09:24 Reconstitution calculator 8,662 ±0 ThymosinTamsin (talk | contribs) add the assumed syringe scale to the readout label [rollback]
  10. (diff | hist) m b 07:00 Contraindications of incretin therapy 4,993 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  11. (diff | hist) 03:49 Zhuhai Kerui Biotechnology 14,711 +220 TriumphThad (talk | contribs) add category for suppliers in China [rollback]

13 March 2026

  1. (diff | hist) m b 19:09 Bacteriostatic water 4,652 ±0 StubSorterBot (talk | contribs) bot: add stub category [rollback]
  2. (diff | hist) 14:15 Talk:High-performance liquid chromatography 748 +83 PrepHPLC_Pia (talk | contribs) /* Orthogonal method paragraph */ reply
  3. (diff | hist) 13:34 SURMOUNT trial programme 5,021 ±0 SelectTrialSam (talk | contribs) consistent en dashes in ranges [rollback]
  4. (diff | hist) 13:25 Talk:Crude peptide 611 +130 BalanceBirdie (talk | contribs) /* Crude is not a pejorative */ reply
  5. (diff | hist) 10:40 Talk:High-performance liquid chromatography 537 +247 ResolutionRoo (talk | contribs) /* Orthogonal method paragraph */ new section
  6. (diff | hist) 09:50 Talk:Crude peptide 400 +149 CrudePeptidePearl (talk | contribs) /* Crude is not a pejorative */ new section
  7. (diff | hist) 08:46 Prior authorisation 4,216 ±0 Retention_Time_Rae (talk | contribs) attribute the survey figure to the survey and give its sample size [rollback]
  8. (diff | hist) 07:52 Triple agonist 4,269 ±0 SubQ_Solveig (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  9. (diff | hist) 06:41 Peptide stability table 6,886 ±0 NavboxNiko (talk | contribs) expand §The table [rollback]
  10. (diff | hist) m b 02:01 Survodutide 5,445 ±0 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]

12 March 2026

  1. (diff | hist) m 22:35 Cold chain 27,220 ±0 CDMO_Caradoc (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) 19:48 MOTS-c 4,670 ±0 DiagramDelphine (talk | contribs) fix a broken wikilink [rollback]
  3. (diff | hist) 18:58 Contract development and manufacturing organisation 5,011 ±0 SPPS_Sorrel (talk | contribs) expand §Consequences for reading documentation [rollback]
  4. (diff | hist) 15:52 Residual solvent 5,085 ±0 SigFigSindri (talk | contribs) add the counterion determination method by name [rollback]
  5. (diff | hist) 13:20 Flourishglobal Peptide Biotech 14,771 ±0 CounterfeitCato (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  6. (diff | hist) 13:20 Talk:Growth hormone secretagogue 611 +90 IpamorelinIsold (talk | contribs) /* Feedback as the limiting factor */ reply
  7. (diff | hist) 11:50 Talk:Glucagon 748 +217 LyophilLena (talk | contribs) /* Fibrillation paragraph belongs here or at aggregation? */ reply
  8. (diff | hist) 11:15 Talk:Temperature excursion 1,444 +122 ParentCatPansy (talk | contribs) /* Should freezing be a separate article? */ reply
  9. (diff | hist) 09:45 Talk:Growth hormone secretagogue 400 +144 SecretagogueSol (talk | contribs) /* Feedback as the limiting factor */ new section
  10. (diff | hist) 09:09 Peptide aggregation 5,516 ±0 IsocraticIla (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]
  11. (diff | hist) 09:05 Talk:Amylin 822 +93 AmylinAmos (talk | contribs) /* Amyloid: cause or consequence? */ reply
  12. (diff | hist) 08:25 Talk:Glucagon 537 +180 StabilityStig (talk | contribs) /* Fibrillation paragraph belongs here or at aggregation? */ new section
  13. (diff | hist) 06:20 Temperature excursion 24,639 ±0 Chromatokid (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  14. (diff | hist) 05:51 Sigma-Aldrich (Shanghai) Trading 18,641 ±0 COA_Colwyn (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]